← Back to Search

Procedure

Total Laparoscopic or Robotic Radical Hysterectomy for Cervical Cancer (LACC Trial)

N/A
Waitlist Available
Research Sponsored by Queensland Centre for Gynaecological Cancer
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients with Histologically confirmed stage IA1 (with lymph vascular invasion), stage IA2, or stage IB1 disease
Histologically confirmed primary adenocarcinoma, squamous cell carcinoma or adenosquamous carcinoma of the uterine cervix;
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 years from surgery
Awards & highlights

LACC Trial Summary

This trial is comparing two types of surgery for cervical cancer, to see which one has better long-term outcomes.

Eligible Conditions
  • Cervical Cancer

LACC Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

LACC Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years from surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 years from surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Disease free survival
Secondary outcome measures
Costs
Feasibility of sentinel lymph node biopsy
Intra-operative, peri-operative, post-operative and long term treatment related morbidity
+4 more

LACC Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: 2Experimental Treatment1 Intervention
Total Laparoscopic or Robotic Radical Hysterectomy
Group II: 1Active Control1 Intervention
Total Abdominal Radical Hysterectomy
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Total Laparoscopic or Robotic Radical Hysterectomy
2008
N/A
~640

Find a Location

Who is running the clinical trial?

Queensland Centre for Gynaecological CancerLead Sponsor
15 Previous Clinical Trials
4,249 Total Patients Enrolled
M.D. Anderson Cancer CenterOTHER
2,958 Previous Clinical Trials
1,797,813 Total Patients Enrolled
Andreas Obermair, MDStudy ChairQueensland Centre for Gynecological Cancer

Frequently Asked Questions

~37 spots leftby Mar 2025